Literature DB >> 19681408

Mechanism of cardiac preconditioning with volatile anaesthetics.

Z-Y Hu1, J Liu.   

Abstract

In recent years, there has been increased interest in the mechanisms involved in anaesthetic-induced cardioprotection. It is not thoroughly understood how volatile anaesthetics protect the myocardium from ischaemia or reperfusion injury, but the overall mechanism is likely to be multifactorial. This review examines the recent experimental and clinical research underlying the cellular and molecular mechanisms involved in anaesthetic-induced preconditioning. A variety of intracellular signalling pathways have been implicated in the protective phenomenon. Ischaemic preconditioning and anaesthetic-induced preconditioning share similar molecular mechanisms, including activation of guanine nucleotide-binding proteins, triggering of second messenger pathways, activation of multiple kinases, mediation of nitric oxide formation and reactive oxygen species release, maintenance of intracellular and/or mitochondrial Ca2+ homeostasis and moderation of the opening of adenosine-triphosphate-sensitive potassium channels. A more thorough understanding of the multiple signalling steps and the ultimate cytoprotective mechanisms underlying anaesthetic-induced preconditioning may lead to improvements in the management of ischaemia and/or reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681408     DOI: 10.1177/0310057X0903700402

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  9 in total

1.  Age-associated differences in gene expression in response to delayed anesthetic preconditioning.

Authors:  C Zhong; N Fleming; X Lu; P Moore; H Liu
Journal:  Age (Dordr)       Date:  2011-10-19

Review 2.  [Cardioprotection in cardiac surgical patients : Everything good comes from the heart].

Authors:  C Stoppe; P Meybohm; M Coburn; A Goetzenich
Journal:  Anaesthesist       Date:  2016-03       Impact factor: 1.041

3.  Emulsified isoflurane postconditioning produces cardioprotection against myocardial ischemia-reperfusion injury in rats.

Authors:  Zhao-Yang Hu; Geoffrey W Abbott; Ya-Dong Fang; Yue-Sheng Huang; Jin Liu
Journal:  J Physiol Sci       Date:  2013-04-27       Impact factor: 2.781

4.  No renal protection from volatile-anesthetic preconditioning in open heart surgery.

Authors:  Wacharin Sindhvananda; Krit Phisaiphun; Prut Prapongsena
Journal:  J Anesth       Date:  2012-08-12       Impact factor: 2.078

Review 5.  Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury.

Authors:  Bhawana Agarwal; David F Stowe; Ranjan K Dash; Zeljko J Bosnjak; Amadou K S Camara
Journal:  Front Physiol       Date:  2014-09-16       Impact factor: 4.566

Review 6.  The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle.

Authors:  Rick J Alleman; Lalage A Katunga; Margaret A M Nelson; David A Brown; Ethan J Anderson
Journal:  Front Physiol       Date:  2014-09-18       Impact factor: 4.566

Review 7.  Cardioprotection with halogenated gases: how does it occur?

Authors:  Jose Luis Guerrero-Orriach; Juan Jose Escalona Belmonte; Alicia Ramirez Fernandez; Marta Ramirez Aliaga; Manuel Rubio Navarro; Jose Cruz Mañas
Journal:  Drug Des Devel Ther       Date:  2017-03-16       Impact factor: 4.162

8.  Isoflurane preconditioning confers cardioprotection by activation of ALDH2.

Authors:  Xiao-E Lang; Xiong Wang; Ke-Rang Zhang; Ji-Yuan Lv; Jian-Hua Jin; Qing-Shan Li
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death.

Authors:  Zhaoyang Hu; Feng Ju; Lei Du; Geoffrey W Abbott
Journal:  Cardiovasc Diabetol       Date:  2021-10-04       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.